Multiple Myeloma: More Real-World Data Needed To Confirm Effectiveness of New Treatments While real-world data suggest that newer treatments may be improving outcomes among patients with relapsed/refractory multiple myeloma (RRMM), more data are needed to confirm patterns in treatment outcomes, according to research published in Expert Review of Hematology. MM accounts for about 2% of […]

Original article The efficacy of bortezomib in human multiple myeloma cells is enhanced by … Available online 15 September 2020 Summary Background & Aims Although bortezomib as one of the first line medicines that has greatly improved the overall survival of patients with multiple myeloma (MM), undesired drug resistance is frequently observed. Docosahexaenoic acid (DHA) […]

As Myeloma Options Increase, So Do Challenges Recent expansion of treatment options for multiple myeloma has created a good news/bad practice environment for clinicians and patients. Most patients achieve a partial response or better with currently available front-line therapies. Truly refractory disease is increasingly uncommon but “not quite rare,” said Robert Z. Orlowski, MD, PhD, […]

Signs and Symptoms of Multiple Myeloma Professor of Oncology and Internal Medicine, Jens Hillengass, MD, discusses the signs and symptoms of multiple myeloma. Learn more: www.roswellpark.org/cancer/multiple-myeloma

Symptoms and treatment options for blood cancer – animation There are approximately 140 different types of blood cancer. Watch this animation to learn more about blood cancer and gain an insight into what it is like to live with the disease as well as the potential treatment options available. Janssen Oncology understands that every blood […]

Seattle Genetics Lands $1.72B From Merck in Pair of Cancer Drug Deals September 14th, 2020 Xconomy Seattle —  Seattle Genetics is in line to receive $1.72 billion from Merck via a pair of deals, one for a cancer drug that’s still in development and the other for partial rights to a therapy that won FDA […]

Multiple Myeloma: New Drugs on the Horizon Earn CME: https://www.naccme.com/program/19-lm-05 In this webcast from the ‘Multiple Myeloma: Treatment Challenges and Updates’ symposium during the 2019 Lymphoma & Myeloma conference in New York, Dr. Kenneth C. Anderson discusses new drugs on the horizon for the treatment of multiple myeloma. © 2019 Imedex, an HMP Company